Global Biosimilar Monoclonal Antibody Market 2018 by Manufacturers, Countries, Type and Application, Forecast to 2023

  • receipt Report ID : 146492
  • calendar_today Published On: Apr, 2019
  • file_copy Pages: 137
  • list Pharmaceuticals and Healthcare

Scope of the Report:

This report studies the Biosimilar Monoclonal Antibody market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Biosimilar Monoclonal Antibody market by product type and applications/end industries.

Biosimilar monoclonal antibodies (mAbs) are complex, large proteins of the biosimilar family used by the immune system to identify and neutralize foreign bodies, such as bacteria, viruses, and others. These antibodies are normally administered in the treatment of diseases such as rheumatoid arthritis, Hodgkins lymphoma, chronic lymphocytic leukemia, and others.

The global Biosimilar Monoclonal Antibody market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Biosimilar Monoclonal Antibody.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Biocon

Accord Healthcare

AET Biotech

Amgen

Celltrion

Reddy's Laboratories

Hospira

3SBio

Allergan

Alvartis

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Synthetic Chemicals

Biopharmaceuticals

Others

Market Segment by Applications, can be divided into

Chronic & Autoimmune Diseases

Oncology

Others

Frequently Asked Questions

The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.

Market is segmented on the basis:

  • By Type
  • By Application
  • By Region
  • By Country
  • By Manufacturer

The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.

The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.

Table of Contents

1 Biosimilar Monoclonal Antibody Market Overview

1.1 Product Overview and Scope of Biosimilar Monoclonal Antibody

1.2 Classification of Biosimilar Monoclonal Antibody by Types

1.2.1 Global Biosimilar Monoclonal Antibody Revenue Comparison by Types (2017-2023)

1.2.2 Global Biosimilar Monoclonal Antibody Revenue Market Share by Types in 2017

1.2.3 Synthetic Chemicals

1.2.4 Biopharmaceuticals

1.2.5 Others

1.3 Global Biosimilar Monoclonal Antibody Market by Application

1.3.1 Global Biosimilar Monoclonal Antibody Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Chronic & Autoimmune Diseases

1.3.3 Oncology

1.3.4 Others

1.4 Global Biosimilar Monoclonal Antibody Market by Regions

1.4.1 Global Biosimilar Monoclonal Antibody Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Biosimilar Monoclonal Antibody Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Biosimilar Monoclonal Antibody Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Biosimilar Monoclonal Antibody Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Biosimilar Monoclonal Antibody Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Biosimilar Monoclonal Antibody Status and Prospect (2013-2023)

1.5 Global Market Size of Biosimilar Monoclonal Antibody (2013-2023)

2 Manufacturers Profiles

2.1 Biocon

2.1.1 Business Overview

2.1.2 Biosimilar Monoclonal Antibody Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Biocon Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.2 Accord Healthcare

2.2.1 Business Overview

2.2.2 Biosimilar Monoclonal Antibody Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Accord Healthcare Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.3 AET Biotech

2.3.1 Business Overview

2.3.2 Biosimilar Monoclonal Antibody Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 AET Biotech Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.4 Amgen

2.4.1 Business Overview

2.4.2 Biosimilar Monoclonal Antibody Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Amgen Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.5 Celltrion

2.5.1 Business Overview

2.5.2 Biosimilar Monoclonal Antibody Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Celltrion Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.6 Reddy's Laboratories

2.6.1 Business Overview

2.6.2 Biosimilar Monoclonal Antibody Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Reddy's Laboratories Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.7 Hospira

2.7.1 Business Overview

2.7.2 Biosimilar Monoclonal Antibody Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Hospira Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.8 3SBio

2.8.1 Business Overview

2.8.2 Biosimilar Monoclonal Antibody Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 3SBio Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.9 Allergan

2.9.1 Business Overview

2.9.2 Biosimilar Monoclonal Antibody Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Allergan Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

2.10 Alvartis

2.10.1 Business Overview

2.10.2 Biosimilar Monoclonal Antibody Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Alvartis Biosimilar Monoclonal Antibody Revenue, Gross Margin and Market Share (2016-2017)

3 Global Biosimilar Monoclonal Antibody Market Competition, by Players

3.1 Global Biosimilar Monoclonal Antibody Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Biosimilar Monoclonal Antibody Players Market Share

3.2.2 Top 10 Biosimilar Monoclonal Antibody Players Market Share

3.3 Market Competition Trend

4 Global Biosimilar Monoclonal Antibody Market Size by Regions

4.1 Global Biosimilar Monoclonal Antibody Revenue and Market Share by Regions

4.2 North America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

4.3 Europe Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

4.5 South America Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

5 North America Biosimilar Monoclonal Antibody Revenue by Countries

5.1 North America Biosimilar Monoclonal Antibody Revenue by Countries (2013-2018)

5.2 USA Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

5.3 Canada Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

5.4 Mexico Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

6 Europe Biosimilar Monoclonal Antibody Revenue by Countries

6.1 Europe Biosimilar Monoclonal Antibody Revenue by Countries (2013-2018)

6.2 Germany Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

6.3 UK Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

6.4 France Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

6.5 Russia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

6.6 Italy Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Countries

7.1 Asia-Pacific Biosimilar Monoclonal Antibody Revenue by Countries (2013-2018)

7.2 China Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

7.3 Japan Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

7.4 Korea Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

7.5 India Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

8 South America Biosimilar Monoclonal Antibody Revenue by Countries

8.1 South America Biosimilar Monoclonal Antibody Revenue by Countries (2013-2018)

8.2 Brazil Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

8.3 Argentina Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

8.4 Colombia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Biosimilar Monoclonal Antibody by Countries

9.1 Middle East and Africa Biosimilar Monoclonal Antibody Revenue by Countries (2013-2018)

9.2 Saudi Arabia Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

9.3 UAE Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

9.4 Egypt Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

9.5 Nigeria Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

9.6 South Africa Biosimilar Monoclonal Antibody Revenue and Growth Rate (2013-2018)

10 Global Biosimilar Monoclonal Antibody Market Segment by Type

10.1 Global Biosimilar Monoclonal Antibody Revenue and Market Share by Type (2013-2018)

10.2 Global Biosimilar Monoclonal Antibody Market Forecast by Type (2018-2023)

10.3 Synthetic Chemicals Revenue Growth Rate (2013-2023)

10.4 Biopharmaceuticals Revenue Growth Rate (2013-2023)

10.5 Others Revenue Growth Rate (2013-2023)

11 Global Biosimilar Monoclonal Antibody Market Segment by Application

11.1 Global Biosimilar Monoclonal Antibody Revenue Market Share by Application (2013-2018)

11.2 Biosimilar Monoclonal Antibody Market Forecast by Application (2018-2023)

11.3 Chronic & Autoimmune Diseases Revenue Growth (2013-2018)

11.4 Oncology Revenue Growth (2013-2018)

11.5 Others Revenue Growth (2013-2018)

12 Global Biosimilar Monoclonal Antibody Market Size Forecast (2018-2023)

12.1 Global Biosimilar Monoclonal Antibody Market Size Forecast (2018-2023)

12.2 Global Biosimilar Monoclonal Antibody Market Forecast by Regions (2018-2023)

12.3 North America Biosimilar Monoclonal Antibody Revenue Market Forecast (2018-2023)

12.4 Europe Biosimilar Monoclonal Antibody Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Biosimilar Monoclonal Antibody Revenue Market Forecast (2018-2023)

12.6 South America Biosimilar Monoclonal Antibody Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Biosimilar Monoclonal Antibody Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Biosimilar Monoclonal Antibody Picture

Table Product Specifications of Biosimilar Monoclonal Antibody

Table Global Biosimilar Monoclonal Antibody and Revenue (Millio

Please fill the form below, to recieve the report sample


+1

Choose License Type

Reach Us

Email us at

sales@mrinsights.biz

Or call us on

US +1-201-465-4211

IND +91-906-779-0957

Why Choose Us

ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems

Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system

Global Outreach6 Major regions and 40+ countries level analysis accomplished

Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery